DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
3.640
-0.050 (-1.36%)
At close: Jul 26, 2024, 4:00 PM
3.510
-0.130 (-3.57%)
After-hours: Jul 26, 2024, 5:55 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $155.58 million as of July 26, 2024. Its market cap has increased by 52.08% in one year.
Market Cap
155.58M
Enterprise Value
111.58M
1-Year Change
52.08%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $155.58M, an increase of 323.93%. That is a compound annual growth rate of 29.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 140.10M | 29.96% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 149.58M |
| Invivyd | 149.15M |
| InfuSystem Holdings | 148.00M |
| OptiNose | 147.74M |
| Elevation Oncology | 147.52M |
| Zomedica | 146.99M |
| Alpha Tau Medical | 145.88M |
| Agenus | 145.11M |